67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details


臨床試験数 : 216 薬物数 : 219 - (DrugBank : 50) / 標的遺伝子数 : 39 - 標的パスウェイ数 : 151

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000012865
2014/06/3001/03/2014Ursodeoxycholic acid for polycystic liver diseaseUrsodeoxycholic acid for polycystic liver disease - UDCA for PLD polycystic liver disease, polycystic kidney diseaseUDCA 600mg/day
standard treatment
Nephrology Center, Toranomon HospitalNULLRecruitingNot applicableNot applicableMale and Female100Not selectedJapan
2NCT02021110
(ClinicalTrials.gov)
December 201312/12/2013Ursodeoxycholic Acid as Treatment for Polycystic Liver DiseaseAn International, Multicenter, Randomized Controlled Clinical Trial Assessing the Efficacy of Ursodeoxycholic Acid as a Volume Reducing Treatment in Symptomatic Polycystic Liver DiseasePolycystic Liver Disease;Polycystic Kidney, Autosomal DominantDrug: Ursodeoxycholic AcidRadboud UniversityAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Completed18 Years80 YearsAll34Phase 2Netherlands;Spain
3EUCTR2013-003207-19-NL
(EUCTR)
29/11/201308/08/2013Trial to investigate the effect of ursodeoxycholic acid as a treatment of symptoms in polycystic liver disease: the CURSOR-trialAn international, multicenter, randomized controlled clinical trial assessing the efficacy of Ursodeoxycholic acid as a volume reducing treatment for symptomatic polycystic livers - The CURSOR trial Patients suffering from symptomatic polycystic liver disease (PLD) with underlying diagnosis of isolated polycystic liver disease (PCLD) or autosomal dominant kidney disease (ADPKD);Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]Trade Name: URSOCHOL 300Radboud University Nijmegen Medical CenterNULLNot RecruitingFemale: yes
Male: yes
34Phase 4Spain;Netherlands